Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124014122 | 12401412 | 2 | F | 20160214 | 20160705 | 20160525 | 20160715 | EXP | IT-MINISAL02-359242 | IT-TEVA-661595ACC | TEVA | 73.40 | YR | M | Y | 75.00000 | KG | 20160715 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124014122 | 12401412 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 289 MG TOTAL | Y | 77269 | 289 | MG | SOLUTION FOR INFUSION | ||||||
| 124014122 | 12401412 | 2 | SS | PEMETREXED DISODIUM | PEMETREXED DISODIUM | 1 | 547 MG TOTAL | Y | 0 | 547 | MG | SOLUTION FOR INFUSION | |||||||
| 124014122 | 12401412 | 3 | C | JAKAVI - 5 MG - COMPRESSA | 2 | Oral | 10 MG | Y | 0 | 10 | MG | TABLET | |||||||
| 124014122 | 12401412 | 4 | C | PANTORC - 40 MG - COMPRESSE GASTRORESISTENTI | 2 | Oral | 40 MG | U | 0 | 40 | MG | CAPSULE, HARD | |||||||
| 124014122 | 12401412 | 5 | C | ZYLORIC - 300 MG COMPRESSE | 2 | Oral | 150 MG | U | 0 | 150 | MG | TABLET | |||||||
| 124014122 | 12401412 | 6 | C | ZOLOFT - 50 MG - COMPRESSE RIVESTITE CON FILM | 2 | Oral | 25 MG | U | 0 | 25 | MG | TABLET | |||||||
| 124014122 | 12401412 | 7 | C | MOVICOL - 13.8 G - POLVERE PER SOLUZIONE ORALE | 2 | Oral | 13.8 G | U | 0 | 13.8 | G | GRANULES | |||||||
| 124014122 | 12401412 | 8 | C | OMNIC - 0,4 MG CAPSULE RIGIDE A RILASCIO MODIFICATO | 2 | Oral | .4 MG | U | 0 | .4 | MG | CAPSULE, HARD | |||||||
| 124014122 | 12401412 | 9 | C | CARDIOASPIRIN - 100 MG COMPRESSE GASTRORESISTENTI | ASPIRIN | 1 | Oral | 100 MG | Y | 0 | 100 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124014122 | 12401412 | 1 | Lung neoplasm malignant |
| 124014122 | 12401412 | 2 | Lung neoplasm malignant |
| 124014122 | 12401412 | 3 | Myelofibrosis |
| 124014122 | 12401412 | 4 | Gastrooesophageal reflux prophylaxis |
| 124014122 | 12401412 | 5 | Hyperuricaemia |
| 124014122 | 12401412 | 6 | Depression |
| 124014122 | 12401412 | 7 | Astringent therapy |
| 124014122 | 12401412 | 8 | Benign prostatic hyperplasia |
| 124014122 | 12401412 | 9 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124014122 | 12401412 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124014122 | 12401412 | Anaemia | |
| 124014122 | 12401412 | Cough | |
| 124014122 | 12401412 | Neutropenia | |
| 124014122 | 12401412 | Pyrexia | |
| 124014122 | 12401412 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124014122 | 12401412 | 1 | 20160208 | 20160208 | 0 | |
| 124014122 | 12401412 | 2 | 20160208 | 20160208 | 0 |